FSPM Stock Overview
FusionPharm, Inc. develops, manufactures, and sells a line of cultivation containers under the PharmPod brand name in the United States.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
FusionPharm, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.0001 |
52 Week High | US$0.015 |
52 Week Low | US$0.000001 |
Beta | 0 |
1 Month Change | 9,900.00% |
3 Month Change | n/a |
1 Year Change | 0% |
3 Year Change | -99.62% |
5 Year Change | -99.76% |
Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
FSPM | US Food | US Market | |
---|---|---|---|
7D | 0% | -3.3% | -3.1% |
1Y | 0% | -14.5% | 20.9% |
Return vs Industry: FSPM exceeded the US Food industry which returned -14.9% over the past year.
Return vs Market: FSPM underperformed the US Market which returned 22.4% over the past year.
Price Volatility
FSPM volatility | |
---|---|
FSPM Average Weekly Movement | n/a |
Food Industry Average Movement | 4.9% |
Market Average Movement | 6.1% |
10% most volatile stocks in US Market | 16.7% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: FSPM's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine FSPM's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1998 | n/a | William Sears | www.fusionpharminc.com |
FusionPharm, Inc. develops, manufactures, and sells a line of cultivation containers under the PharmPod brand name in the United States. Its PharmPods cultivation container system is used in the indoor plant cultivation. The company also offers its products to businesses, universities, and individuals to cultivate various plants.
FusionPharm, Inc. Fundamentals Summary
FSPM fundamental statistics | |
---|---|
Market cap | US$1.26k |
Earnings (TTM) | -US$363.93k |
Revenue (TTM) | US$328.70k |
0.0x
P/S Ratio0.0x
P/E RatioIs FSPM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
FSPM income statement (TTM) | |
---|---|
Revenue | US$328.70k |
Cost of Revenue | US$261.69k |
Gross Profit | US$67.01k |
Other Expenses | US$430.94k |
Earnings | -US$363.93k |
Last Reported Earnings
Mar 31, 2012
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did FSPM perform over the long term?
See historical performance and comparison